Advert: 728x90PTsubInsight
line
Menu top
Menu bottom
Website and Archive search
  Go
JobSearch
  Go
  Advert: Europharm100312
MAGAZINE AUDIT BY
ABC Logo
Where am I? > Home > Industry News > World News
Hline
Advert: ABPIJan2010PT
LATEST WORLD NEWS Rss Feed    
FDA turns down once-weekly Byetta
Amylin, Eli Lilly and Alkermes will have to wait a bit longer before they can start selling a once-weekly version of its diabetes blockbuster Byetta as regulators in the USA want clarification on the labelling

 FDA issues boxed warning for ‘poor metabolisers’ of Plavix
Regulators in the USA have hit Sanofi-Aventis and Bristol-Myers Squibb with a new black box warning about the reduced effectiveness of their anti-clotting blockbuster Plavix in potentially a sizeable chunk of patients

 Recordati signs deal to sell Zanidip in China
Recordati has inked an agreement that will see Lee's Pharmaceutical Holdings market the Italian firm’s big-selling blood pressure tablet Zanidip in China

 		GSK's Revolade approved in EU, will take on Amgen's Nplate
GlaxoSmithKline and partner Ligand Pharmaceuticals are celebrating the news that their blood disorder drug Revolade has gained marketing approval in the European Union

 Belgium's Ablynx raises 50 million euros in tough climate
Ablynx has raised 50 million euros which may allow the Belgian firm to commercialise its own cardiovascular products one day

 Docs recommend best reps for PharmaTimes awards
Over 1,300 doctors have made their nominations for the PharmaTimes Representative of the Year 2010 event, with AstraZeneca’s staff leading the way
More Headlines
Arrow Avastin disappoints in prostate cancer study
Arrow Ipsen signs obesity deal with Rhythm
Arrow Pfizer’s Sutent fails in breast cancer trials
Arrow Australia: top 20 cancer drug sales to hit US$1B by 2018
Arrow J&J asks EMA to reconsider Basilea’s superbug drug
Arrow AstraZeneca inks branded generics pact with India's Torrent
Arrow Germany confirms compulsory drug price deals
Arrow Novartis gets option to license Transgene's lung cancer vaccine
Arrow India leads the world in generics exports, says govt
Arrow FDA rejects Actelion's Zavesca for rare NP-C disease
Arrow FDA panel backs InterMune's Esbriet for IPF
Arrow Abbott Labs to buy Facet Biotech in $722 million deal

Older >
 
Join PharmaTimes Directors Club
Arrow Find out more
PharmaTimes Club for Directors Secretaries
Arrow Learn more
LATEST JOBS
Arrow   Part-time Medical Representative
Arrow   Account Manager/Senior Account Manager Flexible Remote Home Working
Arrow   Market Access Specialist
Arrow   Principal Analyst: Corporate
Arrow   Compliance Manager
Arrow   Junior Editor, Healthcare Communications
Arrow   Product Specialist UK & Nordics or Asia Pacific - Healthcare
Arrow   BUSINESS DEVELOPMENT MANAGER - HOMECARE
Arrow   Project Director Pharmaceutical Market Research
Arrow   PRODUCT MANAGER - HOMECARE
line
flickrtwitteryoutube